- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Weight Management
Recent news which mentions Weight Management
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
December 08, 2024
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
December 05, 2024
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
December 04, 2024
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
From CNBC.com News
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
September 12, 2024
From CNBC.com News
If you invested $1,000 in drugmaker Eli Lilly 10 years ago, here's how much money you'd have now
August 08, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
February 28, 2024
From CNBC.com News
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
February 16, 2024
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
October 24, 2023
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
From CNBC.com News
Tickers
CEO
From CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
September 27, 2023
From CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
From CNBC.com News
From CNBC.com News
Weight loss drugs boost sales at retail pharmacies, but they may not help profits much
August 21, 2023
From CNBC.com News
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
August 16, 2023
From CNBC.com News
From CNBC.com News
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
August 09, 2023
From CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
July 27, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.